SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
NVIDIA Corporation (NVDA.US) launches CUDA 13.1 and CUDA Tile, Huang Renxun claims it is the biggest upgrade in twenty years
Continue to continue to add chips to the AI infrastructure! SoftBank is in talks to privatize DigitalBridge (DBRG.US), with JP Morgan valued at $35 per share.
After winning the "epic" streaming media acquisition battle, Netflix (NFLX.US) is facing a global anti-monopoly "encirclement."
NVIDIA Corporation (NVDA.US) launches CUDA 13.1 and CUDA Tile, Huang Renxun claims it is the biggest upgrade in twenty years
Continue to continue to add chips to the AI infrastructure! SoftBank is in talks to privatize DigitalBridge (DBRG.US), with JP Morgan valued at $35 per share.
After winning the "epic" streaming media acquisition battle, Netflix (NFLX.US) is facing a global anti-monopoly "encirclement."
